NCT05176080 2024-12-17
Famitinib Plus SHR6390 and Endocrine Therapy in the Treatment of HR-positive, HER2-negative Advanced Breast Cancer
Henan Cancer Hospital
Phase 1/2 Terminated
Henan Cancer Hospital
National Cancer Center, Korea
French National Agency for Research on AIDS and Viral Hepatitis